Vimarsana
Biggest News Aggregation in the World

Page 23 - Clinical Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Testing Today - Breaking & Trending Today

CRISPR-based microfluidic platform detects respiratory viruses and SARS-CoV-2 variants - Vimarsana News

CRISPR-based microfluidic platform detects respiratory viruses and SARS-CoV-2 variants

Researchers in the US have developed a novel multiplexed diagnostic platform based on CRISPR-based approaches and microfluidics - enabling robust and simultaneous surveillance of multiple viruses and viral variants. Currently, the paper is available on the medRxiv* preprint server pending peer review.

Lateral Flow Assays Market worth $11.4 billion by 2026 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Lateral Flow Assays Market worth $11.4 billion by 2026 - Exclusive Report by MarketsandMarkets™

/PRNewswire/ -- According to the new market research report "Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases...

Lateral Flow Assays Market worth $11.4 billion by 2026 - Exclusive Report by MarketsandMarkets - Vimarsana News

Lateral Flow Assays Market worth $11.4 billion by 2026 - Exclusive Report by MarketsandMarkets

CHICAGO, Dec. 15, 2021 /PRNewswire/ -- According to the new market research report "Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza

Illumina supports Norway's pioneering precision medicine study - Vimarsana News

Illumina supports Norway's pioneering precision medicine study

Illumina said it supports a study in Norway to assess the efficacy of blood-based comprehensive genomic profiling in cancer therapy selection testing.

Rare Disease Diversity Coalition Urges Congress to Preserve Incentives for Development of Treatments - Vimarsana News

Rare Disease Diversity Coalition Urges Congress to Preserve Incentives for Development of Treatments

/PRNewswire/ -- The Rare Disease Diversity Coalition recently sent a letter urging lawmakers not to change the Orphan Drug Act as part of the budget...